NM_021098.3:c.5113G>A
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021098.3(CACNA1H):c.5113G>A(p.Ala1705Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00716 in 1,611,068 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1705A) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11  | c.5113G>A | p.Ala1705Thr | missense_variant | Exon 29 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6  | c.5128G>A | p.Ala1710Thr | missense_variant | Exon 28 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1  | c.5131G>A | p.Ala1711Thr | missense_variant | Exon 28 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7  | c.5095G>A | p.Ala1699Thr | missense_variant | Exon 28 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1  | c.5128G>A | p.Ala1710Thr | missense_variant | Exon 29 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6  | c.5113G>A | p.Ala1705Thr | missense_variant | Exon 29 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1  | c.5074G>A | p.Ala1692Thr | missense_variant | Exon 29 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6  | c.5095G>A | p.Ala1699Thr | missense_variant | Exon 28 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1  | c.5056G>A | p.Ala1686Thr | missense_variant | Exon 28 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1  | c.5113G>A | p.Ala1705Thr | missense_variant | Exon 29 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1  | c.5095G>A | p.Ala1699Thr | missense_variant | Exon 28 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1  | c.5113G>A | p.Ala1705Thr | missense_variant | Exon 29 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1  | c.5113G>A | p.Ala1705Thr | missense_variant | Exon 29 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1  | c.5113G>A | p.Ala1705Thr | missense_variant | Exon 29 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2  | n.5113G>A | non_coding_transcript_exon_variant | Exon 29 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3  | n.*1065G>A | non_coding_transcript_exon_variant | Exon 28 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1  | n.*194G>A | non_coding_transcript_exon_variant | Exon 29 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1  | n.*2964G>A | non_coding_transcript_exon_variant | Exon 29 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1  | n.*4557G>A | non_coding_transcript_exon_variant | Exon 27 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1  | n.5095G>A | non_coding_transcript_exon_variant | Exon 28 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1  | n.5095G>A | non_coding_transcript_exon_variant | Exon 28 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1  | n.*114G>A | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1  | n.5113G>A | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1  | n.5113G>A | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1  | n.5095G>A | non_coding_transcript_exon_variant | Exon 28 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1  | n.5113G>A | non_coding_transcript_exon_variant | Exon 29 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1  | n.5113G>A | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1  | n.*114G>A | non_coding_transcript_exon_variant | Exon 28 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3  | n.*1065G>A | 3_prime_UTR_variant | Exon 28 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1  | n.*194G>A | 3_prime_UTR_variant | Exon 29 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1  | n.*2964G>A | 3_prime_UTR_variant | Exon 29 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1  | n.*4557G>A | 3_prime_UTR_variant | Exon 27 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711451.1  | n.*114G>A | 3_prime_UTR_variant | Exon 29 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711488.1  | n.*114G>A | 3_prime_UTR_variant | Exon 28 of 35 | ENSP00000518777.1 | 
Frequencies
GnomAD3 genomes   AF:  0.00570  AC: 868AN: 152210Hom.:  5  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.00556  AC: 1356AN: 243960 AF XY:  0.00551   show subpopulations 
GnomAD4 exome  AF:  0.00731  AC: 10664AN: 1458740Hom.:  37  Cov.: 33 AF XY:  0.00711  AC XY: 5161AN XY: 725390 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.00570  AC: 869AN: 152328Hom.:  5  Cov.: 33 AF XY:  0.00502  AC XY: 374AN XY: 74486 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Benign:6 
- -
- -
- -
CACNA1H: BS2 -
- -
- -
not specified    Benign:1 
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at